Neurohospitalist | Former KUMC Vascular Neurology Fellow | Former Academic Initiatives Specialist | @UMKCmedschool Grad | @MissouriWestern Biochemistry Grad
Kansas City
Joined August 2020
- Tweets55
- Following77
- Followers21
- Likes50
On this week's edition of #tweetorial Tuesday:
Statins, they're just for the heart, right? 🫀
Wrong. Hyperlipidemia management is one of the biggest levers we have to prevent a second stroke—but many survivors never reach guideline-directed LDL targets
#MedEd #NeuroTwitter
Questions remain about optimal LDL thresholds in different stroke subtypes, long‑term safety of ultra‑low LDL levels, and how best to personalize therapy in complex patients
Ongoing and future trials will likely refine targets and broaden the evidence base for non‑statin agents
This image may help elucidate hyperlipidemia management for secondary stroke prevention in your stroke/TIA patients (generated using Gemini). Please read more below and stay tuned for next week!
ahajournals.org/doi/10.1161/…
ahajournals.org/doi/10.1161/…
neuro.wiki/journal/stroke/th…
🤖 Made with AI
13/ As for the takeaway? It seems some of the push for devices may be driven by patient preference to have one procedure and never look back, compared to a lifelong prescription. Based on these trials:
- For most AF patients who can tolerate DOACs, they remain first-line
